Adverse effects of COVID-19 vaccines and measures to prevent them

被引:26
|
作者
Yamamoto, Kenji [1 ]
机构
[1] Okamura Mem Hosp, Ctr Varicose Veins, Dept Cardiovasc Surg, 293-1 Kakita Shimizu Cho, Shizuoka 4110904, Japan
关键词
COVID-19; Risk factor; Critically ill patients; Vaccination; Vaccine-acquired immunodeficiency syndrome; RISK;
D O I
10.1186/s12985-022-01831-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible. The decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. As a safety measure, further booster vaccinations should be discontinued. In addition, the date of vaccination should be recorded in the medical record of patients. Several practical measures to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression. In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] COVID-19 Vaccines
    Hahn, William O.
    Wiley, Zanthia
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2022, 36 (02) : 481 - 494
  • [42] Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database
    Karam, Rita
    Iskandar, Katia
    Watfa, Myriam
    Zeitoun, Abeer
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [43] A Narrative Review of COVID-19 Vaccines
    Eroglu, Barbaros
    Nuwarda, Rina Fajri
    Ramzan, Iqbal
    Kayser, Veysel
    VACCINES, 2022, 10 (01)
  • [44] Myocarditis With COVID-19 mRNA Vaccines
    Bozkurt, Biykem
    Kamat, Ishan
    Hotez, Peter J.
    CIRCULATION, 2021, 144 (06) : 471 - 484
  • [45] Evaluation of the effectiveness and adverse effects of COVID-19 vaccines administered at Kashan University of Medical Sciences
    Soleimani, Zahra
    Esalatmanesh, Kamal
    Kashani, Mohammad Mehdi Safaaddin
    Azadchehr, Mohammad Javad
    Esalatmanesh, Roozbeh
    INTERNATIONAL ARCHIVES OF HEALTH SCIENCES, 2024, 11 (02) : 85 - 92
  • [46] COVID-19, vaccines, and thrombotic events
    Abrignani, Maurizio Giuseppe
    Murrone, Adriano
    De Luca, Leonardo
    Roncon, Loris
    Di Lenarda, Andrea
    Valente, Serafina
    Caldarola, Pasquale
    Riccio, Carmine
    Oliva, Fabrizio
    Gulizia, Michele Massimo
    Gabrielli, Domenico
    Colivicchi, Furio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2021, 22 (12) : 969 - 980
  • [47] Ethical reflections on Covid-19 vaccines
    Raus, Kasper
    Mortier, Eric
    Eeckloo, Kristof
    ACTA CLINICA BELGICA, 2022, 77 (03) : 600 - 605
  • [48] COVID-19 mRNA vaccines and myopericarditis
    Gnanenthiran, Sonali R.
    Limaye, Sandhya
    INTERNAL MEDICINE JOURNAL, 2023, 53 (02) : 172 - 177
  • [49] Adverse Cardiovascular Effects of COVID-19 Vaccination: A Systematic Review
    Huang, Jen-Hung
    Ju, Ke-Shiuan
    Liao, Tzu-Wei
    Lin, Yung-Kuo
    Yeh, Jong-Shiuan
    Chen, Yi-Jen
    CARDIOLOGY IN REVIEW, 2024, 32 (04) : 314 - 319
  • [50] COVID-19 vaccines: A ray of hope
    Chand, Neha
    Mathur, Rajani
    Dwivedi, Shridhar
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2021, 12 (04) : 188 - 193